Anti-KIFC2 functional antibody

Anti-KIFC2 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to KIFC2/KIFC2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1582-Ab-1/ GM-Tg-hg-SE1582-Ab-2Anti-Human KIFC2 monoclonal antibodyHuman
GM-Tg-rg-SE1582-Ab-1/ GM-Tg-rg-SE1582-Ab-2Anti-Rat KIFC2 monoclonal antibodyRat
GM-Tg-mg-SE1582-Ab-1/ GM-Tg-mg-SE1582-Ab-2Anti-Mouse KIFC2 monoclonal antibodyMouse
GM-Tg-cynog-SE1582-Ab-1/ GM-Tg-cynog-SE1582-Ab-2Anti-Cynomolgus/ Rhesus macaque KIFC2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1582-Ab-1/ GM-Tg-felg-SE1582-Ab-2Anti-Feline KIFC2 monoclonal antibodyFeline
GM-Tg-cang-SE1582-Ab-1/ GM-Tg-cang-SE1582-Ab-2Anti-Canine KIFC2 monoclonal antibodyCanine
GM-Tg-bovg-SE1582-Ab-1/ GM-Tg-bovg-SE1582-Ab-2Anti-Bovine KIFC2 monoclonal antibodyBovine
GM-Tg-equg-SE1582-Ab-1/ GM-Tg-equg-SE1582-Ab-2Anti-Equine KIFC2 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1582-Ab-1/ GM-Tg-hg-SE1582-Ab-2; GM-Tg-rg-SE1582-Ab-1/ GM-Tg-rg-SE1582-Ab-2;
GM-Tg-mg-SE1582-Ab-1/ GM-Tg-mg-SE1582-Ab-2; GM-Tg-cynog-SE1582-Ab-1/ GM-Tg-cynog-SE1582-Ab-2;
GM-Tg-felg-SE1582-Ab-1/ GM-Tg-felg-SE1582-Ab-2; GM-Tg-cang-SE1582-Ab-1/ GM-Tg-cang-SE1582-Ab-2;
GM-Tg-bovg-SE1582-Ab-1/ GM-Tg-bovg-SE1582-Ab-2; GM-Tg-equg-SE1582-Ab-1/ GM-Tg-equg-SE1582-Ab-2
Products NameAnti-KIFC2 monoclonal antibody
Formatmab
Target NameKIFC2
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-KIFC2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1582-Ag-1Recombinant multi-species KIFC2 protein


    Target information

    Target IDGM-SE1582
    Target NameKIFC2
    Gene ID90990,16581,300053,702650,475128,101096949,789523,100064823
    Gene Symbol and SynonymsKIFC2
    Uniprot AccessionQ96AC6
    Uniprot Entry NameKIFC2_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000167702
    Target ClassificationN/A

    The target: KIFC2, gene name: KIFC2, also named as . Predicted to enable microtubule binding activity and microtubule motor activity. Predicted to be involved in microtubule-based movement and mitotic spindle assembly. Predicted to be located in cytoplasm. Predicted to be part of kinesin complex. Predicted to be active in microtubule cytoskeleton and nucleus. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.